# Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients

> **NCT01826422** · NA · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 40 (actual)

## Conditions studied

- Muscular Dystrophy, Duchenne

## Interventions

- **DIETARY_SUPPLEMENT:** EPA and DHA
- **DIETARY_SUPPLEMENT:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01826422
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01826422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01826422, "Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01826422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*